Delivery Order SPE2DR25D2003-SPE2DR26FR02K
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $11,897.40. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement with an ultimate completion date of November 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Rifampin 300 mg capsules (60-count units) with a ceiling value of $3,089.08. The contract is firm fixed price with an ultimate completion date of August 1, 2025, and was awarded on July 31, 2025, with no set-aside designation. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) valued at $2,401.32, with an ultimate completion date of August 27, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $1,707.48 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules in unit dose packaging (100 count). The contract was competitively awarded without set-aside provisions under a firm fixed price arrangement, with an ultimate completion date of August 14, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.92 to AmerisourceBergen Drug Corp for Rifampin 150 mg capsules (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (quantity 60) under a firm fixed-price contract valued at $4,135.61, with an ultimate completion date of August 4, 2025. This non-set-aside award was competitively procured and represents a child contract under AmerisourceBergen's larger federal contract portfolio. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $17,169.04 delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (30-count) on July 17, 2025, with a completion date of July 18, 2025. This is a firm fixed-price contract with no set-aside designation, awarded through open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Rifampin 300 mg capsules (60-count) with a contract ceiling value of $1,200.66. This is a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 28, 2025, for the supply of Rifampin 300 mg capsules (60-count units) at a ceiling value of $1,720.96. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for ultimate completion by July 29, 2025. The award falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $27,146.46 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on December 4, 2025, with a completion date of December 5, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- SPE2DR25D2003Indefinite Delivery Contract
- SPE2DR25D2003-SPE2DR26FR02KDelivery Order
The Defense Logistics Agency awarded a Delivery Order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) under a firm fixed-price contract valued at $4,367.12, with an ultimate completion date of December 11, 2025. This non-set-aside award represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems worldwide. This delivery order for rifampin, a key antibiotic used in the treatment of tuberculosis and other serious bacterial infections, fulfills an essential medical supply need within the company's extensive portfolio of generic and brand-name medications, vaccines, and specialized healthcare commodities. The award reflects AmerisourceBergen's demonstrated capability to meet federal procurement requirements through competitive bidding, consistent with the company's ongoing strategic role as a pharmaceutical prime vendor for the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 12/9/25 |